Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study
Titel:
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study
Auteur:
Goldman, Jonathan W. Garassino, Marina Chiara Chen, Yuanbin Özgüroğlu, Mustafa Dvorkin, Mikhail Trukhin, Dmytro Statsenko, Galina Hotta, Katsuyuki Ji, Jun Ho Hochmair, Maximilian J. Voitko, Oleksandr Havel, Libor Poltoratskiy, Artem Losonczy, György Reinmuth, Niels Patel, Nikunj Laud, Peter J. Shire, Norah Jiang, Haiyi Paz-Ares, Luis